Just Out📣 On 📰 🇯🇵 Study sees that more than 60% of responders to immune checkpoint inhibitors🧪in the treatment of #lungcancer had immune related adverse events⚠️& showed a strong correlation between irAEs & efficacy in responders📈 #LCSM